In ApoE−/− mice, which serve as a dual model for atherosclerosis and AD, the administration of CA markedly improved spatial memory and reduced hippocampal Aβ burden, while simultaneously decreasing systemic and cerebral inflammation. The gene discussed is APOE; the disease is Alzheimer disease.